NCT06617845Recruiting
Optimizing Brain Stimulation Parameters
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
A primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study will help assess the effectiveness of low frequency or high frequency stimulation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 25 Sept 2024
- Start date
- 20 Oct 2020
- Primary completion date
- 1 Sept 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Epilepsy
- NCT number
- NCT06617845
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 20 Oct 2020 to the primary completion date, 1 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients for whom clinical follow-up is not expected during the initial 6-8 months following implant
Who the study is looking for
- Patients who are implanted with a brain stimulation device targeting the anterior nucleus of the thalamus per Mayo Clinic standard of care
Age in the registry: 6 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic - Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.